UBS Group Cuts Select Medical (NYSE:SEM) Price Target to $21.00

Select Medical (NYSE:SEM) had its price target dropped by analysts at UBS Group from $40.00 to $21.00 in a research report issued on Friday,Benzinga reports. The brokerage currently has a “neutral” rating on the health services provider’s stock. UBS Group’s price objective would indicate a potential upside of 11.76% from the company’s previous close.

SEM has been the topic of a number of other research reports. Royal Bank of Canada increased their price objective on Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Benchmark downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. Finally, StockNews.com downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a research note on Monday. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $39.50.

Select Medical Trading Down 0.3 %

Shares of SEM stock opened at $18.79 on Friday. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. Select Medical has a 1-year low of $18.02 and a 1-year high of $40.98. The firm has a market capitalization of $2.43 billion, a PE ratio of 8.78, a P/E/G ratio of 0.39 and a beta of 1.43. The business’s fifty day moving average price is $27.17 and its 200 day moving average price is $32.32.

Select Medical (NYSE:SEM) last announced its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, topping the consensus estimate of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.74 billion. During the same quarter in the previous year, the company earned $0.46 EPS. The company’s quarterly revenue was up 5.7% on a year-over-year basis. As a group, sell-side analysts forecast that Select Medical will post 1.97 EPS for the current fiscal year.

Insider Buying and Selling at Select Medical

In other Select Medical news, VP Robert G. Breighner, Jr. sold 4,989 shares of the business’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the transaction, the vice president now directly owns 30,356 shares of the company’s stock, valued at $605,602.20. The trade was a 14.12 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Marilyn B. Tavenner sold 32,000 shares of Select Medical stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total value of $674,880.00. Following the sale, the director now directly owns 22,000 shares in the company, valued at approximately $463,980. This trade represents a 59.26 % decrease in their position. The disclosure for this sale can be found here. 19.14% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Kingsview Wealth Management LLC acquired a new stake in Select Medical in the 3rd quarter valued at about $1,927,000. Dynamic Technology Lab Private Ltd acquired a new stake in Select Medical during the third quarter valued at approximately $1,592,000. Hood River Capital Management LLC bought a new stake in Select Medical during the second quarter worth approximately $14,819,000. Geode Capital Management LLC grew its position in Select Medical by 2.0% in the third quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock worth $85,180,000 after buying an additional 46,880 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Select Medical during the 3rd quarter valued at $1,320,000. Institutional investors and hedge funds own 89.48% of the company’s stock.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.